We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
+0.07%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$3.88B
AUM Growth
-$118M
Cap. Flow
-$102M
Cap. Flow %
-2.64%
Top 10 Hldgs %
31.78%
Holding
508
New
48
Increased
124
Reduced
195
Closed
45

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$30.5M
2
MCD icon
McDonald's
MCD
+$30.2M
3
EBAY icon
eBay
EBAY
+$27.3M
4
AME icon
Ametek
AME
+$26.4M
5
NWL icon
Newell Brands
NWL
+$18.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.17%
2 Financials 11.1%
3 Technology 10.64%
4 Healthcare 10.07%
5 Consumer Staples 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
26
Ametek
AME
$58.2B
$45.1M 1.16%
898,356
-509,423
-36% -$26.4M
MRK icon
27
Merck
MRK
$318B
$44M 1.13%
777,844
-80,396
-9% -$4.51M
BKNG icon
28
Booking.com
BKNG
$161B
$43.6M 1.12%
939,850
+308,650
+49% +$15.2M
DHR icon
29
Danaher
DHR
$144B
$43.5M 1.12%
852,171
-157,031
-16% -$8.07M
TJX icon
30
TJX Companies
TJX
$178B
$39.8M 1.03%
1,344,552
-12,466
-0.9% -$352K
RTX icon
31
RTX Corp
RTX
$301B
$38.8M 1%
584,116
+79,926
+16% +$5.48M
NKE icon
32
Nike
NKE
$61.9B
$36.8M 0.95%
825,980
+46,100
+6% +$1.83M
NWL icon
33
Newell Brands
NWL
$2.56B
$34.9M 0.9%
1,014,154
-550,347
-35% -$18.2M
SLB icon
34
SLB Ltd
SLB
$75B
$33M 0.85%
324,260
+126,574
+64% +$13.8M
CVS icon
35
CVS Health
CVS
$122B
$32.1M 0.83%
403,619
-24,093
-6% -$1.9M
WBC
36
DELISTED
WABCO HOLDINGS INC.
WBC
$29.5M 0.76%
323,877
-48,172
-13% -$4.86M
XOM icon
37
ExxonMobil
XOM
$634B
$28.1M 0.72%
298,933
-47,980
-14% -$4.78M
MU icon
38
Micron Technology
MU
$991B
$26M 0.67%
758,782
+744,175
+5,095% +$24.1M
GILD icon
39
Gilead Sciences
GILD
$165B
$25.5M 0.66%
239,882
+11,959
+5% +$1.17M
SLB icon
40
CALL
SLB Ltd
SLB
$75B
$25M 0.64%
246,113
COO icon
41
Cooper Companies
COO
$14.5B
$23.7M 0.61%
607,716
-180,400
-23% -$7.1M
ABT icon
42
Abbott
ABT
$187B
$23M 0.59%
553,462
+14,608
+3% +$618K
AGN
43
DELISTED
Allergan Inc
AGN
$22.2M 0.57%
124,755
+7,856
+7% +$1.3M
TLT icon
44
iShares 20+ Year Treasury Bond ETF
TLT
$41.7B
$20.5M 0.53%
176,486
+2,331
+1% +$268K
CAM
45
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$20.1M 0.52%
303,278
+49,290
+19% +$3.49M
FTI icon
46
TechnipFMC
FTI
$27.3B
$19.3M 0.5%
478,749
+86,517
+22% +$3.82M
EWJ icon
47
iShares MSCI Japan ETF
EWJ
$23B
$19.3M 0.5%
409,950
-7,825
-2% -$374K
AXP icon
48
American Express
AXP
$230B
$19M 0.49%
217,129
-116,378
-35% -$10.5M
GM icon
49
General Motors
GM
$76.8B
$18.2M 0.47%
568,503
+13,868
+3% +$483K
DE icon
50
Deere & Co
DE
$168B
$18.1M 0.47%
220,782
+37,874
+21% +$3.24M

Similar funds

Banque Pictet & Cie's Q3 2014 Portfolio in Review

As of Q3 2014, Banque Pictet & Cie held 508 positions worth $3.88B, down 3% from $4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Banque Pictet & Cie's Q3 2014 filing shows 48 new, 124 increased, 195 reduced and 45 closed positions. Its largest new stake was International Flavors & Fragrances: 176,476 shares worth $16.9M. The largest sale was Citigroup, an estimated $30.5M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

  • Banque Pictet & Cie's largest Q3 2014 buy was International Flavors & Fragrances: 176,476 shares worth $16.9M.
  • Banque Pictet & Cie added most to Thermo Fisher Scientific in Q3 2014, an estimated $42M increase.
  • Banque Pictet & Cie's biggest Q3 2014 reduction was Citigroup, cutting an estimated $30.5M.
  • Banque Pictet & Cie fully exited ProShares Short Russell2000 in Q3 2014, selling an estimated $8.97M.
  • Banque Pictet & Cie's ten largest holdings make up 32% of its $3.88B portfolio in Q3 2014.
  • Banque Pictet & Cie opened 48 new positions and closed 45 in Q3 2014.
  • Banque Pictet & Cie's portfolio value fell 3% quarter-over-quarter to $3.88B.

Based on Banque Pictet & Cie's 13F filing for Q3 2014, filed 7 Nov 2014.